Kit containing ALL reagents (except indexes) for fusion and gene expression profiling by digital RNAseq
Target List
Covers specific sides of specific exons of the targeted genes based on the Human GRCh38 genome build.Analyzes the expression of the targeted genes.Covers specific hotspots of the targeted genes based on the Human GRCh38 genome build.
Leukemia
Acute Leukemia of Ambiguous Lineage
Acute Lymphoblastic Leukemia (ALL)
ABL1ABL2ACTN4AFDNAFF1AFF3AFF4AGGF1ANLNASNSATF7IPAUTS2BCL11BBCL9BCRBTBD18CASC5CREBBPCRLF2CSF1RDDX3XEBF1ELLELNEML1EP300EPOREPS15ESRRBETV6EWSR1FGFR1FGFR1OPFLT3FOXO4FOXP1FRYLGAS7GPHNHLFHNRNPUL1INPP5DJAK2KMT2AKMT2ELNP1MAML2MEF2DMLLT1MLLT10MLLT3MN1MNX1MYBMYCNCOA2NOTCH1NUP214NUP98P2RY8PAG1PAX5PBX1PCM1PDGFRBPICALMPMLPRDM16RAP1GDS1RARARCSD1RUNX1SALL2SETSFPQSPI1SSBP2STILSTMN1TAF15TAL1TCF3TCF7TET1TYK2USP9XZBTB16ZCCHC7ZMIZ1ZMYM2ZNF384ZNF521ATMBRAFCDKN2ACREBBPCSF3RDNM2EGFRFBXW7GATA2HRASMAP2K1MLH1PAX5PDGFRAPTENSMARCB1
Acute Myeloid Leukemia (AML)
ABI1ABI2ABL1AFDNAFF1AFF4ALKANLNARHGAP26ARHGEF12BCORBCRCASC5CBFA2T3CBFBCBLCCDC88CCEP170BCHD1CHIC2CREBBPDAB2IPDDX10DEKDHHDIAPH2ELLEP300EPS15ERGETV6FGFR1FIP1L1FLNAFNBP1FOXO3FOXO4FRYLFUSGAS7GATA1GLIS2GPHNHAUS1HOXA9HOXC11HOXC13HOXD13IRF2BP2JAK2KAT6AKDM5AKIAA1524KMT2ALASP1LNP1LPPLYNMAML2MECOMMKL1MLF1MLLT1MLLT10MLLT11MLLT3MLLT6MN1MNX1MYBMYH11MYO1FNCKIPSDNCOA2NF1NPM1NSD1NTRK3NUMA1NUP214NUP98PAN3PBX1PCM1PDGFRAPDGFRBPDS5APHF23PICALMPMLPRDM16PRRX1PSIP1PSMA2PTPRRRANBP2RARARBM15RHEBL1RPL22RPN1RUNX1RUNX1T1SARNPSEPT2SEPT5SEPT6SEPT9SETSH3GL1SORBS2STAT5BTAF15TCF3TET1TFGTOP1TOP3ATRIP11TYK2UBA2USP42WHSC1L1WTIPZBTB16ZFYVE19ZNF384ASXL1ATMBCORBRAFCDKN2ACHEK2CREBBPCSF3RDAXXDNM2FLT3GATA2IDH1IDH2JAK1JAK3KITKMT2DKRASMAP2K1MPLMYCNRASPBRM1PDGFRAPPM1DPTENPTPN11RAD21RETRUNX1SMARCB1SRSF2U2AF1WT1
B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Chronic Myeloid Leukemia (CML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms
T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Chronic Neutrophilic Leukemia (CNL)
Lymphoma
Angioimmunoblastic T Cell Lymphomas
Burkitt Lymphomas
Diffuse Large B Cell Lymphomas (DLBCL)
ALKBCL11ABCL6CCND3CIITACLTCIGLL5LPPMAPK13MYCNPM1PIM1RELSQSTM1TBL1XR1TOMM40TP63ZCCHC7ALKAMER1APCARID1AASXL1ATMB2MBCL2BCORBRAFBTKCD79BCDKN2ACNOT3CREBBPCTNNB1CXCR4DNMT3AEZH2FBXW7HLA-AID3IDH2IRS4JAK1JAK3KITKMT2DKRASMAP2K1MED12MSNMYCMYD88NCOR1NFKBIENOTCH2NRASNSD2PAX5PIK3CAPIK3R1PLCG1POT1PPM1DPTENRGS7RHOASF3B1SMOSRSF2STAT3STAT5BSTAT6TERTTRRAPWT1XPO1ZFHX3ZNF479
Follicular Lymphomas
Hodgkin Lymphomas
Mantle Cell Lymphomas
Peripheral T Cell Lymphomas
Other Lymphomas
AIDS-Related Lymphomas
B Cell Lymphomas
Small Lymphocytic Lymphomas
Enteropathy-Type T Cell Lymphomas
Marginal Zone Lymphomas
Mycosis Fungoides (Sezary Syndrome)
NK-T Cell Lymphomas
Primary Central Nervous System Lymphomas
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms
Other Hematological Malignancies
Polycythemia Vera
Commercial Control Samples
Leukemia Subtype Markers
Acute Lymphoblastic Leukemia (ALL)
B Cell Acute Lymphoblastic Leukemia (B-ALL)
T Cell Acute Lymphoblastic Leukemia (T-ALL)
Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia (CLL)
Leukemia Stem Cell & Proliferation Markers
Possible Prognostic Significance
Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia (CLL)
Chemotherapy Resistance Related
Treatment Target or Treatment Indicator
Mechanistic Role in Pathogenesis
Expression Altered due to Genetic Alterations
Acute Lymphoblastic Leukemia (ALL)
Lymphoma